The aims of this work were to define if the CDK4 phosphorylation can be detected in thyroid cancer, whether it is variable and indicative of sensitivity to CDK4/6i and predictable on a biomarker based upon protein and/or mRNA expression. Here, CDK4 is linked to thyroid cancer.